Evidence map›Paper›PMID 41112272›Full record

ArticleFrontiers in immunology2025

Clinical isolates of

Joselyn E Castro, Federico Birnberg-Weiss, María J Toloza, Yasmín A Bertinat, Federico Fuentes, Agustín Peyloubet, Diego Faccone, Sonia A Gómez, Verónica I Landoni, Gabriela C Fernández

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joselyn E CastroLaboratorio de Fisiología de los Procesos Inflamatorios, Instituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Federico Birnberg-WeissLaboratorio de Fisiología de los Procesos Inflamatorios, Instituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
María J TolozaLaboratorio de Genética Hematológica, Instituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Yasmín A BertinatLaboratorio de Fisiología de los Procesos Inflamatorios, Instituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Federico FuentesInstituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Agustín PeyloubetServicio de Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI), ANLIS 'Dr. Carlos G. Malbrán', Ciudad Autónoma de Buenos Aires, Argentina.
Diego FacconeServicio de Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI), ANLIS 'Dr. Carlos G. Malbrán', Ciudad Autónoma de Buenos Aires, Argentina.
Sonia A GómezServicio de Antimicrobianos, Instituto Nacional de Enfermedades Infecciosas (INEI), ANLIS 'Dr. Carlos G. Malbrán', Ciudad Autónoma de Buenos Aires, Argentina.
Verónica I LandoniLaboratorio de Fisiología de los Procesos Inflamatorios, Instituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Gabriela C FernándezLaboratorio de Fisiología de los Procesos Inflamatorios, Instituto de Medicina Experimental (IMEX)-CONICET/Academia Nacional de Medicina de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: We measured PMN functions after challenge with selected clinical isolates of Pr and Ps, and used Results: While PMN were able to partially contain Ps growth at 1 h, at 3 h both Pr and Ps were able to escape PMN-mediated killing compared to Eco, which was efficiently killed. Reactive oxygen species (ROS) generation was not induced by Pr or poorly induced by Ps, compared to Eco, but phagocytosis of Pr, Ps, and Eco was similar. Although Pr and Ps induced the release of double-stranded (d.s.) DNA early at 30 min (vital neutrophils extracellular traps or NETs), the release of late-induced NETs (3 h, suicidal NETs) was not observed, consistent with the absence of PMN death observed with Pr or Ps. In addition, Pr and Ps decreased suicidal NETs when Eco or PMA were used as inducers. This decrease was abolished by fixed bacteria, and was dependent on the release of a DNase activity. Twenty-four h after i.p. inoculation of mice with Pr, Ps or Eco, all bacteria induced migration of PMN to the peritoneum, but no PMN activation or NETs was observed in Pr or Ps-treated mice. When the distribution of bacteria in different organs was measured by CFU determination, Pr and Ps disseminated to the spleen and lungs, whereas Eco was exclusively present in the peritoneum. Discussion: The isolates used in this study of Pr and Ps are poor inducers of bactericidal PMN responses and display immune evasion strategies to subvert PMN-mediated killing. These evasion mechanisms, acting on degrading vital NETs and/or blocking the formation of suicidal NETs, would favor bacterial dissemination.

Indexed as

Enterobacteriaceae InfectionsExtracellular TrapsImmune EvasionNeutrophilsProvidenciaAnimalsHumansMicePhagocytosisReactive Oxygen SpeciesReactive Oxygen Speciesimmune evasionNETsneutrophilsnucleasesProvidencia rettgeriProvidencia stuartii

Identifiers

PMID41112272
PMCPMC12528210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.